Our munKNEE.com's Pot Stock Index (PSI) was up an exceptional 7.6% this past week compared to a 1% decline the previous week and just a 2.6% increase the week before that. The details are as follows:

The pot stock universe has 400+ cannabis-related securities listed on the various Canadian and American stock exchanges of which approx. 300 actively trade. Of those 300 only 25 (that's just 8% of the total) fulfill the criteria for inclusion in the Pot Stock Index of being pure-play* cannabis companies (i.e derive 100% of their revenue from the sale of cannabis or cannabis-related products) whose stocks consistently trade for at least US$1/share.

Below are the major winners and losers for the week ending July 31st.

Major Winners

Three constituents went UP in excess of 20%, namely:

1. Greenlane (GNLN) +25.0%
2. Columbia (CCHWF) +20.3%
3. cbdMD (YCBD) +20.0%

Nine constituents went UP between 10% and 19.9%, namely:

1. Acreage (ACRGF) +19.9%
2. TerrAscend (TRSSF) +14.3%
3. AYR (AYRSF) +13.2%
4. Curaleaf (CURLF) +13.1%
5. Jushi (JUSHF) +12.5%
6. Cresco (CRLBF) +10.9%
7. Planet 13 (PLNHF) +10.6%
8. Canopy (CGC) +10.3%
9. Green Thumb (GTBIF) +10.0%

Another 6 constituents had prices increases of less than 10% for the week.

Major Losers

No constituents went DOWN by 10%, or more.

Six went down at least 5%, namely:

1. Medicine Man (SHWZ) -9.6%
2. Organigram (OGI) -8.2%
3. Neptune (NEPT) -6.4%
4. Aphria (APHA) -6.1%
5. Charlotte's Web (CWBHF) -5.4%
6. Avicanna (AVCNF) -5.2%

Two other constituents had price declines of less than 5% for the week.

Further details regarding the equal-weighted pure-play index are as follows:

• *Unlike every marijuana ETF (see this TalkMarkets article for details) and every other cannabis tracking index (see this TalkMarkets article for details), the PSI inclusion criteria excludes those "wanna-be" marijuana companies who generate little, if any, of their total revenue from the cannabis industry so as to reflect the true health of the marijuana industry in the U.S. and Canada. Those industry companies include:
  • those pharmaceutical companies hoping to include cannabis in future products (GW Pharma only has one such product),
  • those tobacco/alcohol companies with part ownership in marijuana companies (read this TalkMarkets article for details),
  • those companies trying to develop marijuana-infused consumer products,
  • those retailers who also sell some cannabis products,
  • those horticultural and construction companies who do business with marijuana companies,
  • those business service/consulting companies who have marijuana companies as clients, and
  • those real estate investment trusts who do business with marijuana companies.
• The official definition of a "penny" stock is one that trades below US$5/share but, when it comes to pot stocks, that is where 92% of the total universe trades, so the more literal definition of stocks that trade for less than US$1/share is used.
• The market capitalization of the 25 constituents in the PSI is US$962.8M, on average.
• The constituents operate in 3 categories based on their primary area of focus and they are identified below within each applicable category:
  1. The Vertically Integrated (i.e. Seed-to-Sale) Category consists of 22 companies that grow, process, and sell cannabis and hemp flower and related products of which:
     • 8 constituents are Canadian Licensed Producers (LPs), namely: ACB; APHA; CGC; CRON; OGI;   ROMJF; TLRY and VFF
       • and they advanced 4%, on average, this past week.
     • 11 constituents are American Multi-State Operators (MSOs), namely: ACRGF; AYRSF; CCHWF; CRLBF;  CURLF; GTBIF; JUSHF; PLNHF; SHWZ; TRSSF and TCNNF
       • and they advanced 11.2%, on average, this past week.
     • 3 constituents are only involved in the seed-to-sale of CBD from hemp, namely: AVCNF; CWBHF, and  YCBD
       • and they advanced 3.4%, on average, this past week.
  2. The Extraction Category consists of companies focused on the extraction of cannabis compounds and their infusion into consumer products of which:
     • 2 are NPSI constituents, namely: NEPT and VLNCF
       • and they declined by 2.5%, on average, this past week.
  3. The Consumption Devices Category consists of  companies focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers.
     • 1 constituent is in this category, namely, GNLN
       • and it advanced 25.0% this past week.